Zhongsh Ophthalmic Center Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2012
NCT01727973
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 2 Trials (1)

doxycycline (vibramycin) (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Autoimmune Diseases (Phase 2)

Endocrine System Diseases (Phase 2)

Eye Diseases (Phase 2)

Eye Diseases, Hereditary (Phase 2)

Genetic Diseases, Inborn (Phase 2)

Graves Disease (Phase 2)

Graves Ophthalmopathy (Phase 2)

Hyperthyroidism (Phase 2)

Immune System Diseases (Phase 2)

Thyroid Diseases (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 1